Medizinische Universität Graz - Research portal

Logo MUG Resarch Portal

Selected Publication:

SHR Neuro Cancer Cardio Lipid Metab Microb

Aydin, SE; Kilic, SS; Aytekin, C; Kumar, A; Porras, O; Kainulainen, L; Kostyuchenko, L; Genel, F; Kütükcüler, N; Karaca, N; Gonzalez-Granado, L; Abbott, J; Al-Zahrani, D; Rezaei, N; Baz, Z; Thiel, J; Ehl, S; Marodi, L; Orange, JS; Sawalle-Belohradsky, J; Keles, S; Holland, SM; Sanal, Ö; Ayvaz, DC; Tezcan, I; Al-Mousa, H; Alsum, Z; Hawwari, A; Metin, A; Matthes-Martin, S; Hönig, M; Schulz, A; Picard, C; Barlogis, V; Gennery, A; Ifversen, M; van, Montfrans, J; Kuijpers, T; Bredius, R; Dückers, G; Al-Herz, W; Pai, SY; Geha, R; Notheis, G; Schwarze, CP; Tavil, B; Azik, F; Bienemann, K; Grimbacher, B; Heinz, V; Gaspar, HB; Aydin, R; Hagl, B; Gathmann, B; Belohradsky, BH; Ochs, HD; Chatila, T; Renner, ED; Su, H; Freeman, AF; Engelhardt, K; Albert, MH, , inborn, errors, working, party, of, EBMT.
DOCK8 deficiency: clinical and immunological phenotype and treatment options - a review of 136 patients.
J CLIN IMMUNOL. 2015; 35(2): 189-98. Doi: 10.1007/s10875-014-0126-0
Web of Science PubMed FullText FullText_MUG

 

Co-authors Med Uni Graz
Thiel Jens
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
Mutations in DOCK8 result in autosomal recessive Hyper-IgE syndrome with combined immunodeficiency (CID). However, the natural course of disease, long-term prognosis, and optimal therapeutic management have not yet been clearly defined. In an international retrospective survey of patients with DOCK8 mutations, focused on clinical presentation and therapeutic measures, a total of 136 patients with a median follow-up of 11.3 years (1.3-47.7) spanning 1693 patient years, were enrolled. Eczema, recurrent respiratory tract infections, allergies, abscesses, viral infections and mucocutaneous candidiasis were the most frequent clinical manifestations. Overall survival probability in this cohort [censored for hematopoietic stem cell transplantation (HSCT)] was 87 % at 10, 47 % at 20, and 33 % at 30 years of age, respectively. Event free survival was 44, 18 and 4 % at the same time points if events were defined as death, life-threatening infections, malignancy or cerebral complications such as CNS vasculitis or stroke. Malignancy was diagnosed in 23/136 (17 %) patients (11 hematological and 9 epithelial cancers, 5 other malignancies) at a median age of 12 years. Eight of these patients died from cancer. Severe, life-threatening infections were observed in 79/136 (58 %); severe non-infectious cerebral events occurred in 14/136 (10 %). Therapeutic measures included antiviral and antibacterial prophylaxis, immunoglobulin replacement and HSCT. This study provides a comprehensive evaluation of the clinical phenotype of DOCK8 deficiency in the largest cohort reported so far and demonstrates the severity of the disease with relatively poor prognosis. Early HSCT should be strongly considered as a potential curative measure.
Find related publications in this database (using NLM MeSH Indexing)
Adolescent - administration & dosage
Adult - administration & dosage
Child - administration & dosage
Child, Preschool - administration & dosage
Cohort Studies - administration & dosage
Female - administration & dosage
Follow-Up Studies - administration & dosage
Genetic Association Studies - administration & dosage
Guanine Nucleotide Exchange Factors - deficiency, genetics
Humans - administration & dosage
Immunoglobulin E - blood, immunology
Incidence - administration & dosage
Infant - administration & dosage
Infections - diagnosis, epidemiology, etiology
Job Syndrome - complications, diagnosis, genetics, immunology, mortality, therapy
Lymphocyte Count - administration & dosage
Lymphocyte Subsets - immunology, metabolism
Male - administration & dosage
Middle Aged - administration & dosage
Mutation - administration & dosage
Neoplasms - epidemiology, etiology
Phenotype - administration & dosage
Young Adult - administration & dosage

Find related publications in this database (Keywords)
DOCK8 deficiency
combined immunodeficiency
hyper-IgE syndrome
natural outcome
© Med Uni GrazImprint